Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 381

Similar articles for PubMed (Select 23058261)

1.

BDNF Val 66 Met and 5-HTTLPR genotype moderate the impact of early psychosocial adversity on plasma brain-derived neurotrophic factor and depressive symptoms: a prospective study.

Buchmann AF, Hellweg R, Rietschel M, Treutlein J, Witt SH, Zimmermann US, Schmidt MH, Esser G, Banaschewski T, Laucht M, Deuschle M.

Eur Neuropsychopharmacol. 2013 Aug;23(8):902-9. doi: 10.1016/j.euroneuro.2012.09.003. Epub 2012 Oct 9.

PMID:
23058261
2.

Three-way interaction effect of 5-HTTLPR, BDNF Val66Met, and childhood adversity on depression: a replication study.

Comasco E, Åslund C, Oreland L, Nilsson KW.

Eur Neuropsychopharmacol. 2013 Oct;23(10):1300-6. doi: 10.1016/j.euroneuro.2013.01.010. Epub 2013 Mar 6.

PMID:
23481907
3.

Early adversity and 5-HTT/BDNF genes: new evidence of gene-environment interactions on depressive symptoms in a general population.

Aguilera M, Arias B, Wichers M, Barrantes-Vidal N, Moya J, Villa H, van Os J, Ibáñez MI, Ruipérez MA, Ortet G, Fañanás L.

Psychol Med. 2009 Sep;39(9):1425-32. doi: 10.1017/S0033291709005248. Epub 2009 Feb 12.

PMID:
19215635
4.

Genetic epistasis between the brain-derived neurotrophic factor Val66Met polymorphism and the 5-HTT promoter polymorphism moderates the susceptibility to depressive disorders after childhood abuse.

Grabe HJ, Schwahn C, Mahler J, Appel K, Schulz A, Spitzer C, Fenske K, Barnow S, Freyberger HJ, Teumer A, Petersmann A, Biffar R, Rosskopf D, John U, Völzke H.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Mar 30;36(2):264-70. doi: 10.1016/j.pnpbp.2011.09.010. Epub 2011 Oct 2.

PMID:
21996278
5.

The BDNF Val(66)Met x 5-HTTLPR x child adversity interaction and depressive symptoms: An attempt at replication.

Wichers M, Kenis G, Jacobs N, Mengelers R, Derom C, Vlietinck R, van Os J.

Am J Med Genet B Neuropsychiatr Genet. 2008 Jan 5;147B(1):120-3.

PMID:
17579366
6.

Impact of psychosocial adversity on alcohol intake in young adults: moderation by the LL genotype of the serotonin transporter polymorphism.

Laucht M, Treutlein J, Schmid B, Blomeyer D, Becker K, Buchmann AF, Schmidt MH, Esser G, Jennen-Steinmetz C, Rietschel M, Zimmermann US, Banaschewski T.

Biol Psychiatry. 2009 Jul 15;66(2):102-9. doi: 10.1016/j.biopsych.2009.02.010. Epub 2009 Apr 9.

PMID:
19358979
7.

Evidence for plasticity genotypes in a gene-gene-environment interaction: the TRAILS study.

Nederhof E, Bouma EM, Riese H, Laceulle OM, Ormel J, Oldehinkel AJ.

Genes Brain Behav. 2010 Nov;9(8):968-73. doi: 10.1111/j.1601-183X.2010.00637.x.

PMID:
20738408
8.

Effect of BDNF Val66Met and serotonin transporter 5-HTTLPR polymorphisms on psychopathological characteristics in a sample of university students.

Kourmouli N, Samakouri M, Mamatsiou A, Trypsianis G, Livaditis M, Veletza S.

Psychiatr Genet. 2013 Oct;23(5):188-97. doi: 10.1097/YPG.0b013e3283643629.

PMID:
23884433
9.

Childhood adversity interacts separately with 5-HTTLPR and BDNF to predict lifetime depression diagnosis.

Carver CS, Johnson SL, Joormann J, Lemoult J, Cuccaro ML.

J Affect Disord. 2011 Jul;132(1-2):89-93. doi: 10.1016/j.jad.2011.02.001. Epub 2011 Mar 21.

PMID:
21420735
10.

Polymorphisms in BDNF (Val66Met) and 5-HTTLPR, morning cortisol and subsequent depression in at-risk adolescents.

Goodyer IM, Croudace T, Dudbridge F, Ban M, Herbert J.

Br J Psychiatry. 2010 Nov;197(5):365-71. doi: 10.1192/bjp.bp.110.077750.

11.

Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression.

Pezawas L, Meyer-Lindenberg A, Goldman AL, Verchinski BA, Chen G, Kolachana BS, Egan MF, Mattay VS, Hariri AR, Weinberger DR.

Mol Psychiatry. 2008 Jul;13(7):709-16. doi: 10.1038/mp.2008.32. Epub 2008 Mar 18.

PMID:
18347599
12.

Early family environment, current adversity, the serotonin transporter promoter polymorphism, and depressive symptomatology.

Taylor SE, Way BM, Welch WT, Hilmert CJ, Lehman BJ, Eisenberger NI.

Biol Psychiatry. 2006 Oct 1;60(7):671-6. Epub 2006 Aug 24.

PMID:
16934775
13.

Interaction between the 5-HTTLPR serotonin transporter polymorphism and environmental adversity for mood and anxiety psychopathology: evidence from a high-risk community sample of young adults.

Laucht M, Treutlein J, Blomeyer D, Buchmann AF, Schmid B, Becker K, Zimmermann US, Schmidt MH, Esser G, Rietschel M, Banaschewski T.

Int J Neuropsychopharmacol. 2009 Jul;12(6):737-47. doi: 10.1017/S1461145708009875. Epub 2009 Jan 20.

PMID:
19154632
14.

Serotonin transporter and BDNF genetic variants interact to predict cognitive reactivity in healthy adults.

Wells TT, Beevers CG, McGeary JE.

J Affect Disord. 2010 Oct;126(1-2):223-9. doi: 10.1016/j.jad.2010.03.019. Epub 2010 Apr 15.

15.

Emotional distress in parents of psychotic patients is modified by serotonin transporter gene (5-HTTLPR)--brain-derived neurotrophic factor gene interactions.

Golimbet V, Alfimova M, Korovaitseva G, Abramova LI, Kaled VG.

Span J Psychol. 2009 Nov;12(2):696-706.

PMID:
19899670
16.

Interactions between life stressors and susceptibility genes (5-HTTLPR and BDNF) on depression in Korean elders.

Kim JM, Stewart R, Kim SW, Yang SJ, Shin IS, Kim YH, Yoon JS.

Biol Psychiatry. 2007 Sep 1;62(5):423-8. Epub 2007 May 4.

PMID:
17482146
18.

Interaction between a serotonin transporter gene promoter region polymorphism and stress predicts depressive symptoms in Chinese adolescents: a multi-wave longitudinal study.

Ming QS, Zhang Y, Chai QL, Chen HY, Hou CJ, Wang MC, Wang YP, Cai L, Zhu XZ, Yi JY, Yao SQ.

BMC Psychiatry. 2013 May 17;13:142. doi: 10.1186/1471-244X-13-142.

19.

The BDNF Val66Met polymorphism is associated with rumination in healthy adults.

Beevers CG, Wells TT, McGeary JE.

Emotion. 2009 Aug;9(4):579-84. doi: 10.1037/a0016189.

20.

Moderation of adult depression by the serotonin transporter promoter variant (5-HTTLPR), childhood abuse and adult traumatic events in a general population sample.

Grabe HJ, Schwahn C, Mahler J, Schulz A, Spitzer C, Fenske K, Appel K, Barnow S, Nauck M, Schomerus G, Biffar R, Rosskopf D, John U, Völzke H, Freyberger HJ.

Am J Med Genet B Neuropsychiatr Genet. 2012 Apr;159B(3):298-309. doi: 10.1002/ajmg.b.32027. Epub 2012 Feb 10.

PMID:
22328412
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk